MESA LABORATORIES INC /CO Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
MESA LABORATORIES INC /CO (MLAB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-03.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-06-03
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2018-03-31 was $2.07M, a 28.09% decline year-over-year.
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-12-31 was $61.68K, a 95.84% decline year-over-year.
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-09-30 was $1.76M, a 80.37% increase year-over-year.
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-06-30 was $2.42M, a 8.01% increase year-over-year.
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $24.00K, a 0.00% change from fiscal 2024.
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $24.00K, a 99.65% decline from fiscal 2023.
- MESA LABORATORIES INC /CO share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $6.90M, a 54.62% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $0.00 10-K · filed 2026-06-03 | ||||||
| 2025-03-31 | $24.00K 10-K · filed 2026-06-03 | ||||||
| 2024-03-31 | $24.00K 10-K · filed 2026-06-03 | $6.90M 10-K · filed 2024-06-28 | |||||
| 2023-03-31 | $6.90M 10-K · filed 2025-05-28 | ||||||
| 2022-03-31 | $15.21M 10-K · filed 2023-05-30 | ||||||
| 2021-03-31 | $9.56M 10-K · filed 2023-05-30 | ||||||
| 2020-03-31 | $9.57M 10-K · filed 2022-05-31 | ||||||
| 2019-03-31 | $10.89M 10-K · filed 2021-06-01 | ||||||
| 2018-03-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-01 | $2.13M derived: sum of 2 quarters · filed 2020-06-01 | $3.89M derived: sum of 3 quarters · filed 2020-06-01 | $6.31M 10-K · filed 2020-06-01 | |||
| 2017-12-31 | $61.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-06 | $1.82M derived: sum of 2 quarters · filed 2018-02-06 | $4.24M 10-Q · filed 2018-02-06 | $7.12M derived: sum of 4 quarters · filed 2019-06-03 | |||
| 2017-09-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-06 | $4.18M 10-Q · filed 2017-11-06 | $7.05M derived: sum of 3 quarters · filed 2019-06-03 | $8.54M derived: sum of 4 quarters · filed 2019-06-03 | |||
| 2017-06-30 | $2.42M 10-Q · filed 2017-08-01 | $5.30M derived: sum of 2 quarters · filed 2019-06-03 | $6.78M derived: sum of 3 quarters · filed 2019-06-03 | $7.75M derived: sum of 4 quarters · filed 2019-06-03 | |||
| 2017-03-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | $4.36M derived: sum of 2 quarters · filed 2019-06-03 | $5.33M derived: sum of 3 quarters · filed 2019-06-03 | $7.57M 10-K · filed 2019-06-03 | $7.57M 10-K · filed 2017-06-07 | ||
| 2016-12-31 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-06 | $2.46M derived: sum of 2 quarters · filed 2018-02-06 | $4.70M 10-Q · filed 2018-02-06 | $5.70M derived: sum of 4 quarters · filed 2018-06-05 | |||
| 2016-09-30 | $975.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-06 | $3.22M 10-Q · filed 2017-11-06 | $4.21M derived: sum of 3 quarters · filed 2018-06-05 | $5.72M derived: sum of 4 quarters · filed 2018-06-05 | |||
| 2016-06-30 | $2.24M 10-Q · filed 2017-08-01 | $3.24M derived: sum of 2 quarters · filed 2018-06-05 | $4.74M derived: sum of 3 quarters · filed 2018-06-05 | $5.69M derived: sum of 4 quarters · filed 2018-06-05 | |||
| 2016-03-31 | $996.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-05 | $2.50M derived: sum of 2 quarters · filed 2018-06-05 | $3.44M derived: sum of 3 quarters · filed 2018-06-05 | $5.26M 10-K · filed 2018-06-05 | |||
| 2015-12-31 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-06 | $2.45M derived: sum of 2 quarters · filed 2017-02-06 | $4.26M 10-Q · filed 2017-02-06 | $4.26M 10-Q · filed 2016-02-04 | $5.81M derived: sum of 4 quarters · filed 2017-06-07 | ||
| 2015-09-30 | $943.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-07 | $2.76M 10-Q · filed 2016-11-07 | $2.76M 10-Q · filed 2015-11-04 | $4.30M derived: sum of 3 quarters · filed 2017-06-07 | $4.79M derived: sum of 4 quarters · filed 2017-06-07 | ||
| 2015-06-30 | $1.82M 10-Q · filed 2016-08-01 | $3.36M derived: sum of 2 quarters · filed 2017-06-07 | $3.85M derived: sum of 3 quarters · filed 2017-06-07 | $4.54M derived: sum of 4 quarters · filed 2017-06-07 | |||
| 2015-03-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | $2.03M derived: sum of 2 quarters · filed 2017-06-07 | $2.72M derived: sum of 3 quarters · filed 2017-06-07 | $3.55M 10-K · filed 2017-06-07 | |||
| 2014-12-31 | $487.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-04 | $1.18M derived: sum of 2 quarters · filed 2016-02-04 | $2.00M 10-Q · filed 2016-02-04 | $5.40M derived: sum of 4 quarters · filed 2016-06-06 | |||
| 2014-09-30 | $690.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-04 | $1.52M 10-Q · filed 2015-11-04 | $4.91M derived: sum of 3 quarters · filed 2016-06-06 | $6.09M derived: sum of 4 quarters · filed 2016-06-06 | |||
| 2014-06-30 | $826.00K 10-Q · filed 2015-08-04 | $4.22M derived: sum of 2 quarters · filed 2016-06-06 | $5.40M derived: sum of 3 quarters · filed 2016-06-06 | $6.78M derived: sum of 4 quarters · filed 2016-06-06 | |||
| 2014-03-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-06 | $4.58M derived: sum of 2 quarters · filed 2016-06-06 | $5.96M derived: sum of 3 quarters · filed 2016-06-06 | $6.29M 10-K · filed 2016-06-06 | |||
| 2013-12-31 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-02 | $2.56M derived: sum of 2 quarters · filed 2015-02-02 | $2.89M 10-Q · filed 2015-02-02 | ||||
| 2013-09-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-06 | $1.71M 10-Q · filed 2014-11-06 | |||||
| 2013-06-30 | $329.00K 10-Q · filed 2014-08-06 | ||||||
| 2013-03-31 | $2.74M 10-K · filed 2015-06-03 | ||||||
| 2012-03-31 | $2.23M 10-K · filed 2014-06-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senseonics Holdings, Inc. (SENS) | United States | $0.546B | -2.74 |
| HURCO COMPANIES INC (HURC) | United States | $0.140B | -20.39 |
| SYPRIS SOLUTIONS INC (SYPR) | United States | $0.040B | -4.94 |
| ClearSign Technologies Corp (CLIR) | United States | $0.024B | -4.54 |
| FOCUS UNIVERSAL INC. (FCUV) | United States | $0.003B | -0.58 |
| Sensata Technologies Holding plc (ST) | $5.976B | 77.15 | |
| Ralliant Corp (RAL) | United States | $7.737B | -6.14 |
| COGNEX CORP (CGNX) | United States | $9.711B | 65.26 |
| Fortive Corp (FTV) | United States | $16.897B | 31.51 |
| MKS INC (MKSI) | United States | $17.440B | 68.37 |